Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells

Diabetes

Volumn 48, Issue 6, 2000, Pages 1331-1337

  Posch, Karla ^a   Simecek, Sabine ^a   Wascher, Thomas C ^a   Jürgens, Günther ^a   Baumgartner Parzer, Sabina ^b   Kostner, Gert M ^a   Graier, Wolfgang F ^a  

^a UNIVERSITY OF GRAZ   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; ENDOTHELIUM INJURY; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SHEAR STRESS;

ADULT; ARGININE; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; GLYCOSYLATION; HUMANS; LIPOPROTEINS, LDL; MALE; NITRIC OXIDE; STRESS; SUPEROXIDES;

EID: 0345034617     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.6.1331     Document Type: Article

References (45)

1. 2. Am J Physiol 257:H1327-H1333, 1989
2. Meraji S, Jayakody L, Senaratne MPJ, Thomson ABR, Kapagoda T: Endothelium-dependent relaxation in aorta of BB rat. Diabetes 36:978-981, 1987
3. Kamata K, Miyata N, Kasuya Y: Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br J Pharmacol 97:614-618, 1989
4. Graier WF, Posch K, Wascher TC, Kukovetz WR, Kostner GM: Role of superoxide anions in changes of endothelial vasoactive response during acute hyperglycemia. Horm Metab Res 29:622-629, 1997
5. 2+/EDRF signaling are due to generation of superoxide anions. Diabetes 45:1386-1395, 1996
6. Tesfamariam B, Cohen RA: Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263:H321-H326, 1992
7. Pieper GM, Siebeneich W, Dondlinger LA: Short-term oral administration of L-arginine reverses defective endothelium-dependent relaxation and cGMP generation in diabetes. Eur J Pharmacol 317:317-320, 1996
8. Dimitriadis E, Griffin M, Owens D, Johnson A, Collins P, Tomkin GH: Oxidation of low-density lipoprotein in NIDDM: its relationship to fatty acid composition. Diabetologia 38:1300-1306, 1995.
9. Lorenzi M, Cagliero E, Markey B, Henriksen T, Witztum JL, Sampietro T: Interaction of human endothelial cells with elevated glucose concentration and native and glycosylated low density lipoproteins. Diabetologia 26:218-222, 1984
10. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D: Nonenzymatic glycosylation of low-density lipoprotein alters its biologic activity. Diabetes 31:283-291, 1982
11. Colaco CALS, Roser BJ: Atherosclerosis and glycation. BioEssays 16: 145-147, 1994
12. Graier WF, Kostner GM: Glycated LDL and atherosclerosis: the missing link between diabetes mellitus and hypercholesterolemia? Eur J Clin Invest 27: 457-459, 1997
13. Pieper GM, Siebeneich W, Moore-Hilton G, Roza AM: Reversal by L-arginine of a dysfunctional arginine/nitric oxide pathway in the endothelium of the genetic diabetic BB rat. Diabetologia 40:910-915, 1997
14. Chen LY, Metha P, Metha JL: Oxidized LDL decreases L-arginine uptake and nitric oxide synthase protein expression in human platelets: relevance of the effect of oxidized LDL on platelet function. Circulation 93:1740-1746, 1996
15. Hecker M, Sessa WC, Harris HJ, Änggard EE, Vane JR: The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor cultured endothelial cells recycle L-citrulline to L-arginine. Proc Natl Acad Sci U S A 87:8612-8616, 1990
16. Posch K, Graier WF: Selective stimulation of L-arginine uptake contributes to shear stress-induced formation of nitric oxide. Life Sci 64:663-670, 1999
17. Steyrer E, Durovic S, Frank S, Gießauf W, Burger A, Dieplinger H, Zechner R, Kostner GM: The role of lecithin:cholesterol acyltransferase for lipoprotein (a) assembly: structural integrity of low density lipoproteins is a prerequisite for Lp(a) formation in human plasma. J Clin Invest 94:2330-2340, 1994
18. Duell PB, Oram JF, Biermann EL: Nonenzymatic glycosylation of HDL resulting in inhibition of high-affinity binding to cultured human fibroblasts. Diabetes 39:1257-1263, 1990
19. Hammer A, Kager G, Dohr G, Rabl H, Ghassempur I, Jurgens G: Generation, characterization, and histochemical application of monoclonal antibodies selectively recognizing oxidatively modified apoB-containing serum lipoproteins. Arterioscler Thromb Vasc Biol 15:704-713, 1995
20. Greilberger J, Schmut O, Jürgens G: In vitro interaction of oxidized modified low density lipoprotein with collagen type I, II, III, IV and V, Iaminin, fibronectin, and poly-D-lysine. Arterioscler Thromb Vasc Biol 17:2721-2728, 1997
21. Graier WF, Wascher TC, Lackner L, Toplak H, Krejs GJ, Kukovetz WR: Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatatory response. Diabetes 42:1497-1505, 1993
22. Tsao PS, Lewis NP, Alpert S, Cooke JP: Exposure to shear stress alters endothelial adhesiveness. Circulation 92:3513-3519, 1995
23. Fridovich I: Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. J Biol Chem 245:4053-4057, 1970
24. 2+ signaling pathways. Arterioscler Thromb Vasc Biol 18:1470-1479, 1998
25. Steinbrecher UP: Role of superoxide in endothelial-cell modification of low-density lipoproteins. Biochim Biophys Acta 959:20-30, 1988
26. Martin W, White DG, Henderson AH: Endothelium-derived relaxing factor and atriopeptin II elevate cyclic GMP levels in pig aortic endothelial cells. Br J Pharmacol 93:229-239, 1988
27. Kuchan MJ, Frangos JA: Role of calcium and clamodulin in flow-induced nitric oxide production in endothelial cells. Am J Physiol 266:C628-C636, 1994
28. Tesfamariam B, Brown M, Deykin D, Cohen R: Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest 85:929-932, 1990
29. Pieper GM: Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J Cardiovasc Pharmacol 29:8-15, 1997
30. 2+/cGMP response by scavenging superoxide anions. Eur J Pharmacol 322:113-122, 1997
31. Satho H, Togo M, Hara M, Miyata T, Han K, Maekawa H, Ohno M, Hashimoto Y, Kurokawa K, Watanabe T: Advanced glycation endproducts stimulate mitogen-activated protein kinase and proliferation in rabbit vascular smooth muscle cells. Biochem Biophys Res Commun 239:111-115, 1997
32. Chahravarthy U, Hayes RG, Stitt AW, McAuley E, Archer DB: Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. Diabetes 47:945-952, 1998
33. Hori O, Yan SD, Ogawa S, Kuwabara K, Matsumoto M, Stern D, Schmidt AM: The receptor for advanced glycation end-products has a central role in mediating the effects of advanced glycation end-products on the development of vascular disease in diabetes mellitus. Nephrol Dial Transplant 11:13-16, 1996
34. Bucala R, Tracey K, Cerami A: Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilation in experimental diabetes. J Clin Invest 87:432-438, 1991
35. Rodriguez-Manas L, Arribas S, Giron C, Villamor J, Sanchez-Ferrer CF, Marin J: Interference of glycosylated human hemoglobin with endothelium-dependent responses. Circulation 88:2111-2116, 1993
36. Jack CM: Non-enzymatic glycosylation of low-density lipoprotein: results of an affinity chromatography method. Diabetologia 31:126-127, 1988
37. Tames FJ, Mackness MI, Arrol S, Laing I, Durrington PN: Non-enzymatic glycation of apolipoprotein B in the sera of diabetic and non-diabetic subjects. Atherosclerosis 93:237-244, 1992
38. Klein RL, Laimins M, Lopes-Virella MF: Isolation, characterization, and metabolism of the glycated and nonglycated subfraction of low-density lipoproteins isolated from type I diabetic patients and nondiabetics. Diabetes 44: 1093-1098, 1995
39. Kimura H, Minakami H, Kimura S, Sakurai T, Nakamura T, Kurashige S, Nakano M, Shoji A: Release of superoxide radicals by mouse macrophages stimulated by oxidative modification of glycated low density lipoproteins. Atherosclerosis 118:1-8, 1995
40. Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamuea T, Nyengaard JR, van den Enden M, Kilo C, Tilton RG: Hyperglycemic pseudohypoxia and diabetic complications. Diabetes 42:801-813, 1993
41. Mitchell JA, Hecker M, Anggard EE, Vane JR: Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF. Eur J Pharmacol 182:573-576, 1990
42. Gold ME, Wood KS, Byrns RE, Buga GM, Ignarro LJ: L-arginine-dependent vascular smooth muscle relaxation and cGMP formation. Am J Physiol 259: H1813-H1821, 1990
43. + system) and nitric oxide synthase by elevated glucose and insulin in human endothelial cells. J Physiol (Lond) 490:775-781, 1996
44. Pieper GM: Review of alterations in endothelial nitric oxide production in diabetes: protective role of arginine on endothelial dysfunction. Hypertension 31:1047-1060, 1998
45. Jayakody L, Senaratne M, Thomson A, Kappagoda T: Endothelium-dependent relaxation in experimental atherosclerosis in the rabbit. Circ Res 60:251-264, 1987